ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,330.00
-20.00 (-0.37%)
At close: Aug 4, 2025, 3:30 PM KST

Elevation Oncology Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Operating Revenue
654.541107,73335.952.5
Upgrade
Other Revenue
---0-
Upgrade
Revenue
654.541107,73335.952.5
Upgrade
Revenue Growth (YoY)
495.04%-98.58%21413.29%1337.90%66.67%
Upgrade
Cost of Revenue
11.1217.0917.857.85.36
Upgrade
Gross Profit
643.4292.917,71628.15-2.86
Upgrade
Selling, General & Admin
4,9645,0387,6625,0752,958
Upgrade
Research & Development
7,3866,03414,2436,0128,914
Upgrade
Other Operating Expenses
19.6419.5515.1512.633.3
Upgrade
Operating Expenses
13,24211,89022,78911,92412,638
Upgrade
Operating Income
-12,599-11,797-15,073-11,896-12,641
Upgrade
Interest Expense
-6.93-3.13---
Upgrade
Interest & Investment Income
690.31769.15---
Upgrade
Currency Exchange Gain (Loss)
-49.419.5175.7192.4321.03
Upgrade
Other Non Operating Income (Expenses)
6,27819,88611,507-48,783-6,528
Upgrade
EBT Excluding Unusual Items
-5,6868,865-3,490-60,487-19,148
Upgrade
Gain (Loss) on Sale of Assets
-0.55-0.77-1.38-3.18-9.39
Upgrade
Pretax Income
-5,6878,864-3,492-60,490-19,158
Upgrade
Net Income
-5,6878,864-3,492-60,490-19,158
Upgrade
Net Income to Common
-5,6878,864-3,492-60,490-19,158
Upgrade
Shares Outstanding (Basic)
565252465
Upgrade
Shares Outstanding (Diluted)
565252465
Upgrade
Shares Change (YoY)
7.35%0.64%12.17%904.47%-0.01%
Upgrade
EPS (Basic)
-101.00169.00-67.00-1302.00-4142.00
Upgrade
EPS (Diluted)
-101.00169.00-67.00-1302.00-4142.00
Upgrade
Free Cash Flow
-14,750-8,766-15,337-2,078-10,322
Upgrade
Free Cash Flow Per Share
-261.96-167.13-294.29-44.72-2231.70
Upgrade
Gross Margin
98.30%84.47%99.77%78.31%-114.52%
Upgrade
Operating Margin
-1924.80%-10724.51%-194.91%-33093.66%-505642.37%
Upgrade
Profit Margin
-868.86%8058.20%-45.15%-168272.99%-766313.44%
Upgrade
Free Cash Flow Margin
-2253.53%-7968.93%-198.32%-5779.96%-412888.34%
Upgrade
EBITDA
-11,547-10,766-13,992-10,870-11,684
Upgrade
EBITDA Margin
---180.93%--
Upgrade
D&A For EBITDA
1,0511,0311,0811,026956.83
Upgrade
EBIT
-12,599-11,797-15,073-11,896-12,641
Upgrade
EBIT Margin
---194.91%--
Upgrade
Advertising Expenses
11---
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.